APO Research
Talk to an analyst

APO RESEARCH · REPORT

Metronidazole Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Metronidazole Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026188 pages

Choose your research edition.

Industry ResearchMetronidazole Injection Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Metronidazole Injection Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Metronidazole Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Metronidazole Injection Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Metronidazole Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Metronidazole Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Metronidazole Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Metronidazole Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Metronidazole Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Metronidazole Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Metronidazole Injection include Pfizer, Baxter, Unique Pharmaceuticals, Sanofi-Aventis Canada Inc, Sagent Pharmaceuticals, Qatar Pharma, JB Chemicals and Pharmaceuticals, B. Braun Medical Inc and AdvaCare Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Metronidazole Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Metronidazole Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Metronidazole Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Metronidazole Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Metronidazole Injection Segment by Company

Pfizer

Baxter

Unique Pharmaceuticals

Sanofi-Aventis Canada Inc

Sagent Pharmaceuticals

Qatar Pharma

JB Chemicals and Pharmaceuticals

B. Braun Medical Inc

AdvaCare Pharma

Metronidazole Injection Segment by Type

500mg/100mL

50mg/10mL

Metronidazole Injection Segment by Application

Adult Use

Pediatric Use

Geriatric Use

Metronidazole Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metronidazole Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metronidazole Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metronidazole Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Metronidazole Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Metronidazole Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Metronidazole Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Metronidazole Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Metronidazole Injection Industry Trends Table 2. Metronidazole Injection Industry Drivers Table 3. Metronidazole Injection Industry Opportunities and Challenges Table 4. Metronidazole Injection Industry Restraints Table 5. Global Metronidazole Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Metronidazole Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Metronidazole Injection Sales by Manufacturers (K L) & (2021-2026) Table 8. Global Metronidazole Injection Sales Market Share by Manufacturers Table 9. Global Metronidazole Injection Average Sales Price (US$/L) of Manufacturers (2021-2026) Table 10. Global Metronidazole Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Metronidazole Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Metronidazole Injection Manufacturers, Product Type & Application Table 13. Global Metronidazole Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Metronidazole Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 500mg/100mL Table 17. Major Manufacturers of 50mg/10mL Table 18. Global Metronidazole Injection Sales by Type 2021 VS 2025 VS 2032 (K L) Table 19. Global Metronidazole Injection Sales by Type (2021-2026) & (K L) Table 20. Global Metronidazole Injection Sales by Type (2027-2032) & (K L) Table 21. Global Metronidazole Injection Sales Market Share by Type (2021-2026) Table 22. Global Metronidazole Injection Sales Market Share by Type (2027-2032) Table 23. Global Metronidazole Injection Revenue by Type 2021 VS 2025 VS 2032 (K L) Table 24. Global Metronidazole Injection Revenue by Type (2021-2026) & (K L) Table 25. Global Metronidazole Injection Revenue by Type (2027-2032) & (K L) Table 26. Global Metronidazole Injection Revenue Market Share by Type (2021-2026) Table 27. Global Metronidazole Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Adult Use Table 29. Major Manufacturers of Pediatric Use Table 30. Major Manufacturers of Geriatric Use Table 31. Global Metronidazole Injection Sales by Application 2021 VS 2025 VS 2032 (K L) Table 32. Global Metronidazole Injection Sales by Application (2021-2026) & (K L) Table 33. Global Metronidazole Injection Sales by Application (2027-2032) & (K L) Table 34. Global Metronidazole Injection Sales Market Share by Application (2021-2026) Table 35. Global Metronidazole Injection Sales Market Share by Application (2027-2032) Table 36. Global Metronidazole Injection Revenue by Application 2021 VS 2025 VS 2032 (K L) Table 37. Global Metronidazole Injection Revenue by Application (2021-2026) & (K L) Table 38. Global Metronidazole Injection Revenue by Application (2027-2032) & (K L) Table 39. Global Metronidazole Injection Revenue Market Share by Application (2021-2026) Table 40. Global Metronidazole Injection Revenue Market Share by Application (2027-2032) Table 41. Global Metronidazole Injection Sales by Region: 2021 VS 2025 VS 2032 (K L) Table 42. Global Metronidazole Injection Sales by Region (2021-2026) & (K L) Table 43. Global Metronidazole Injection Sales Market Share by Region (2021-2026) Table 44. Global Metronidazole Injection Sales Forecasted by Region (2027-2032) & (K L) Table 45. Global Metronidazole Injection Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Metronidazole Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K L) Table 47. North America Metronidazole Injection Sales by Country (2021-2026) & (K L) Table 48. North America Metronidazole Injection Sales by Country (2027-2032) & (K L) Table 49. Europe Metronidazole Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K L) Table 50. Europe Metronidazole Injection Sales by Country (2021-2026) & (K L) Table 51. Europe Metronidazole Injection Sales by Country (2027-2032) & (K L) Table 52. Asia Pacific Metronidazole Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K L) Table 53. Asia Pacific Metronidazole Injection Sales by Country (2021-2026) & (K L) Table 54. Asia Pacific Metronidazole Injection Sales by Country (2027-2032) & (K L) Table 55. South America, Middle East and Africa Metronidazole Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K L) Table 56. South America, Middle East and Africa Metronidazole Injection Sales by Country (2021-2026) & (K L) Table 57. South America, Middle East and Africa Metronidazole Injection Sales by Country (2027-2032) & (K L) Table 58. Global Metronidazole Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Metronidazole Injection Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Metronidazole Injection Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Metronidazole Injection Revenue Market Share by Region (2021-2026) Table 62. Global Metronidazole Injection Revenue Market Share by Region (2027-2032) Table 63. Pfizer Company Information Table 64. Pfizer Business Overview Table 65. Pfizer Metronidazole Injection Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Pfizer Metronidazole Injection Product Portfolio Table 67. Pfizer Recent Development Table 68. Baxter Company Information Table 69. Baxter Business Overview Table 70. Baxter Metronidazole Injection Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Baxter Metronidazole Injection Product Portfolio Table 72. Baxter Recent Development Table 73. Unique Pharmaceuticals Company Information Table 74. Unique Pharmaceuticals Business Overview Table 75. Unique Pharmaceuticals Metronidazole Injection Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Unique Pharmaceuticals Metronidazole Injection Product Portfolio Table 77. Unique Pharmaceuticals Recent Development Table 78. Sanofi-Aventis Canada Inc Company Information Table 79. Sanofi-Aventis Canada Inc Business Overview Table 80. Sanofi-Aventis Canada Inc Metronidazole Injection Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Sanofi-Aventis Canada Inc Metronidazole Injection Product Portfolio Table 82. Sanofi-Aventis Canada Inc Recent Development Table 83. Sagent Pharmaceuticals Company Information Table 84. Sagent Pharmaceuticals Business Overview Table 85. Sagent Pharmaceuticals Metronidazole Injection Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Sagent Pharmaceuticals Metronidazole Injection Product Portfolio Table 87. Sagent Pharmaceuticals Recent Development Table 88. Qatar Pharma Company Information Table 89. Qatar Pharma Business Overview Table 90. Qatar Pharma Metronidazole Injection Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Qatar Pharma Metronidazole Injection Product Portfolio Table 92. Qatar Pharma Recent Development Table 93. JB Chemicals and Pharmaceuticals Company Information Table 94. JB Chemicals and Pharmaceuticals Business Overview Table 95. JB Chemicals and Pharmaceuticals Metronidazole Injection Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. JB Chemicals and Pharmaceuticals Metronidazole Injection Product Portfolio Table 97. JB Chemicals and Pharmaceuticals Recent Development Table 98. B. Braun Medical Inc Company Information Table 99. B. Braun Medical Inc Business Overview Table 100. B. Braun Medical Inc Metronidazole Injection Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. B. Braun Medical Inc Metronidazole Injection Product Portfolio Table 102. B. Braun Medical Inc Recent Development Table 103. AdvaCare Pharma Company Information Table 104. AdvaCare Pharma Business Overview Table 105. AdvaCare Pharma Metronidazole Injection Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. AdvaCare Pharma Metronidazole Injection Product Portfolio Table 107. AdvaCare Pharma Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Metronidazole Injection Distributors List Table 111. Metronidazole Injection Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Metronidazole Injection Product Image Figure 2. Global Metronidazole Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Metronidazole Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Metronidazole Injection Sales (2021-2032) & (K L) Figure 5. Global Metronidazole Injection Average Price (US$/L) & (2021-2032) Figure 6. Global Top 5 and 10 Metronidazole Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 500mg/100mL Image Figure 9. 50mg/10mL Image Figure 10. Global Metronidazole Injection Sales by Type (2021 VS 2025 VS 2032) & (K L) Figure 11. Global Metronidazole Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Metronidazole Injection Sales Market Share by Type (2021-2032) Figure 13. Global Metronidazole Injection Revenue by Type (2021 VS 2025 VS 2032) & (K L) Figure 14. Global Metronidazole Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Metronidazole Injection Revenue Market Share by Type (2021-2032) Figure 16. Adult Use Image Figure 17. Pediatric Use Image Figure 18. Geriatric Use Image Figure 19. Global Metronidazole Injection Sales by Application (2021 VS 2025 VS 2032) & (K L) Figure 20. Global Metronidazole Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Metronidazole Injection Sales Market Share by Application (2021-2032) Figure 22. Global Metronidazole Injection Revenue by Application (2021 VS 2025 VS 2032) & (K L) Figure 23. Global Metronidazole Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Metronidazole Injection Revenue Market Share by Application (2021-2032) Figure 25. North America Metronidazole Injection Sales and Growth Rate (2021-2032) & (K L) Figure 26. North America Metronidazole Injection Sales Market Share by Country (2021-2032) Figure 27. U.S. Metronidazole Injection Sales and Growth Rate (2021-2032) & (K L) Figure 28. Canada Metronidazole Injection Sales and Growth Rate (2021-2032) & (K L) Figure 29. Mexico Metronidazole Injection Sales and Growth Rate (2021-2032) & (K L) Figure 30. Europe Metronidazole Injection Sales and Growth Rate (2021-2032) & (K L) Figure 31. Europe Metronidazole Injection Sales Market Share by Country (2021-2032) Figure 32. Germany Metronidazole Injection Sales and Growth Rate (2021-2032) & (K L) Figure 33. France Metronidazole Injection Sales and Growth Rate (2021-2032) & (K L) Figure 34. U.K. Metronidazole Injection Sales and Growth Rate (2021-2032) & (K L) Figure 35. Italy Metronidazole Injection Sales and Growth Rate (2021-2032) & (K L) Figure 36. Netherlands Metronidazole Injection Sales and Growth Rate (2021-2032) & (K L) Figure 37. Asia Pacific Metronidazole Injection Sales and Growth Rate (2021-2032) & (K L) Figure 38. Asia Pacific Metronidazole Injection Sales Market Share by Country (2021-2032) Figure 39. China Metronidazole Injection Sales and Growth Rate (2021-2032) & (K L) Figure 40. Japan Metronidazole Injection Sales and Growth Rate (2021-2032) & (K L) Figure 41. South Korea Metronidazole Injection Sales and Growth Rate (2021-2032) & (K L) Figure 42. Southeast Asia Metronidazole Injection Sales and Growth Rate (2021-2032) & (K L) Figure 43. India Metronidazole Injection Sales and Growth Rate (2021-2032) & (K L) Figure 44. Australia Metronidazole Injection Sales and Growth Rate (2021-2032) & (K L) Figure 45. South America, Middle East and Africa Metronidazole Injection Sales and Growth Rate (2021-2032) & (K L) Figure 46. South America, Middle East and Africa Metronidazole Injection Sales Market Share by Country (2021-2032) Figure 47. Brazil Metronidazole Injection Sales and Growth Rate (2021-2032) & (K L) Figure 48. South Africa Metronidazole Injection Sales and Growth Rate (2021-2032) & (K L) Figure 49. Saudi Arabia Metronidazole Injection Sales and Growth Rate (2021-2032) & (K L) Figure 50. Turkey Metronidazole Injection Sales and Growth Rate (2021-2032) & (K L) Figure 51. Argentina Metronidazole Injection Sales and Growth Rate (2021-2032) & (K L) Figure 52. UAE Metronidazole Injection Sales and Growth Rate (2021-2032) & (K L) Figure 53. Egypt Metronidazole Injection Sales and Growth Rate (2021-2032) & (K L) Figure 54. Chile Metronidazole Injection Sales and Growth Rate (2021-2032) & (K L) Figure 55. Global Metronidazole Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Metronidazole Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Metronidazole Injection Revenue (2021-2032) & (US$ Million) Figure 58. North America Metronidazole Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Metronidazole Injection Revenue (2021-2032) & (US$ Million) Figure 60. Europe Metronidazole Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Metronidazole Injection Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Metronidazole Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Metronidazole Injection Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Metronidazole Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Metronidazole Injection Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Metronidazole Injection Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 500mg/100mL
  • 50mg/10mL
Applications
  • Adult Use
  • Pediatric Use
  • Geriatric Use
Companies covered
  • Pfizer
  • Baxter
  • Unique Pharmaceuticals
  • Sanofi-Aventis Canada Inc
  • Sagent Pharmaceuticals
  • Qatar Pharma
  • JB Chemicals and Pharmaceuticals
  • B. Braun Medical Inc
  • AdvaCare Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Metronidazole Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Metronidazole Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Metronidazole Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Metronidazole Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Metronidazole Injection Market Dynamics
  1. 2.1 Metronidazole Injection Industry Trends
  2. 2.2 Metronidazole Injection Industry Drivers
  3. 2.3 Metronidazole Injection Industry Opportunities and Challenges
  4. 2.4 Metronidazole Injection Industry Restraints
3 Metronidazole Injection Market by Manufacturers
  1. 3.1 Global Metronidazole Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Metronidazole Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Metronidazole Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Metronidazole Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Metronidazole Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Metronidazole Injection Manufacturers, Product Type & Application
  7. 3.7 Global Metronidazole Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Metronidazole Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Metronidazole Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Metronidazole Injection Tier 1, Tier 2, and Tier 3
4 Metronidazole Injection Market by Type
  1. 4.1 Metronidazole Injection Type Introduction
  2. 4.1.1 500mg/100mL
  3. 4.1.2 50mg/10mL
  4. 4.2 Global Metronidazole Injection Sales by Type
  5. 4.2.1 Global Metronidazole Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Metronidazole Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Metronidazole Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Metronidazole Injection Revenue by Type
  9. 4.3.1 Global Metronidazole Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Metronidazole Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Metronidazole Injection Revenue Market Share by Type (2021-2032)
5 Metronidazole Injection Market by Application
  1. 5.1 Metronidazole Injection Application Introduction
  2. 5.1.1 Adult Use
  3. 5.1.2 Pediatric Use
  4. 5.1.3 Geriatric Use
  5. 5.2 Global Metronidazole Injection Sales by Application
  6. 5.2.1 Global Metronidazole Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Metronidazole Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Metronidazole Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Metronidazole Injection Revenue by Application
  10. 5.3.1 Global Metronidazole Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Metronidazole Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Metronidazole Injection Revenue Market Share by Application (2021-2032)
6 Global Metronidazole Injection Sales by Region
  1. 6.1 Global Metronidazole Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Metronidazole Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Metronidazole Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Metronidazole Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Metronidazole Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Metronidazole Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Metronidazole Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Metronidazole Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Metronidazole Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Metronidazole Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Metronidazole Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Metronidazole Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Metronidazole Injection Revenue by Region
  1. 7.1 Global Metronidazole Injection Revenue by Region
  2. 7.1.1 Global Metronidazole Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Metronidazole Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Metronidazole Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Metronidazole Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Metronidazole Injection Revenue (2021-2032)
  8. 7.2.2 North America Metronidazole Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Metronidazole Injection Revenue (2021-2032)
  11. 7.3.2 Europe Metronidazole Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Metronidazole Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Metronidazole Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Metronidazole Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Metronidazole Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Pfizer
  2. 8.1.1 Pfizer Company Information
  3. 8.1.2 Pfizer Business Overview
  4. 8.1.3 Pfizer Metronidazole Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Pfizer Metronidazole Injection Product Portfolio
  6. 8.1.5 Pfizer Recent Developments
  7. 8.2 Baxter
  8. 8.2.1 Baxter Company Information
  9. 8.2.2 Baxter Business Overview
  10. 8.2.3 Baxter Metronidazole Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Baxter Metronidazole Injection Product Portfolio
  12. 8.2.5 Baxter Recent Developments
  13. 8.3 Unique Pharmaceuticals
  14. 8.3.1 Unique Pharmaceuticals Company Information
  15. 8.3.2 Unique Pharmaceuticals Business Overview
  16. 8.3.3 Unique Pharmaceuticals Metronidazole Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Unique Pharmaceuticals Metronidazole Injection Product Portfolio
  18. 8.3.5 Unique Pharmaceuticals Recent Developments
  19. 8.4 Sanofi-Aventis Canada Inc
  20. 8.4.1 Sanofi-Aventis Canada Inc Company Information
  21. 8.4.2 Sanofi-Aventis Canada Inc Business Overview
  22. 8.4.3 Sanofi-Aventis Canada Inc Metronidazole Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sanofi-Aventis Canada Inc Metronidazole Injection Product Portfolio
  24. 8.4.5 Sanofi-Aventis Canada Inc Recent Developments
  25. 8.5 Sagent Pharmaceuticals
  26. 8.5.1 Sagent Pharmaceuticals Company Information
  27. 8.5.2 Sagent Pharmaceuticals Business Overview
  28. 8.5.3 Sagent Pharmaceuticals Metronidazole Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sagent Pharmaceuticals Metronidazole Injection Product Portfolio
  30. 8.5.5 Sagent Pharmaceuticals Recent Developments
  31. 8.6 Qatar Pharma
  32. 8.6.1 Qatar Pharma Company Information
  33. 8.6.2 Qatar Pharma Business Overview
  34. 8.6.3 Qatar Pharma Metronidazole Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Qatar Pharma Metronidazole Injection Product Portfolio
  36. 8.6.5 Qatar Pharma Recent Developments
  37. 8.7 JB Chemicals and Pharmaceuticals
  38. 8.7.1 JB Chemicals and Pharmaceuticals Company Information
  39. 8.7.2 JB Chemicals and Pharmaceuticals Business Overview
  40. 8.7.3 JB Chemicals and Pharmaceuticals Metronidazole Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 JB Chemicals and Pharmaceuticals Metronidazole Injection Product Portfolio
  42. 8.7.5 JB Chemicals and Pharmaceuticals Recent Developments
  43. 8.8 B. Braun Medical Inc
  44. 8.8.1 B. Braun Medical Inc Company Information
  45. 8.8.2 B. Braun Medical Inc Business Overview
  46. 8.8.3 B. Braun Medical Inc Metronidazole Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 B. Braun Medical Inc Metronidazole Injection Product Portfolio
  48. 8.8.5 B. Braun Medical Inc Recent Developments
  49. 8.9 AdvaCare Pharma
  50. 8.9.1 AdvaCare Pharma Company Information
  51. 8.9.2 AdvaCare Pharma Business Overview
  52. 8.9.3 AdvaCare Pharma Metronidazole Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 AdvaCare Pharma Metronidazole Injection Product Portfolio
  54. 8.9.5 AdvaCare Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Metronidazole Injection Value Chain Analysis
  2. 9.1.1 Metronidazole Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Metronidazole Injection Production Mode & Process
  6. 9.2 Metronidazole Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Metronidazole Injection Distributors
  9. 9.2.3 Metronidazole Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst